Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04521140 · ClinicalTrials.gov registry record · Phase 4
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
A Phase 4 study of Intraocular Pressure and Corneal Edema, sponsored by Nicole Fram M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT04521140 is a Phase 4 study of Intraocular Pressure and Corneal Edema that has completed, run by Nicole Fram M.D.. The registered enrollment target is 36 participants, below the 84-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04521140, a Phase 4 study of Intraocular Pressure and Corneal Edema, has completed, sponsored by Nicole Fram M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Assessing the efficacy and safety of DEXTENZA, sustained release dexamethasone 0.4 mg insert following corneal transplant surgery (PKP, DSEK, DMEK) as compared to topical prednisolone acetate 1%.
Conditions Studied
Interventions
- DRUG Prednisolone Acetate 1% Oph Susp
- DRUG Dextenza 0.4Mg Ophthalmic Insert
Study Locations (1)
California
- Advanced Vision Care - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-10-16 |
| Est. Completion | 2023-01-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04521140
The ClinicalTrials.gov registry entry for NCT04521140 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (57% lower). The listed sponsor is Nicole Fram M.D., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Intraocular Pressure appearing as the primary indexed condition, and to 2 interventions - of which Prednisolone Acetate 1% Oph Susp is the first listed.
NCT04521140 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04521140 about?
NCT04521140 is a clinical study titled "Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery". Assessing the efficacy and safety of DEXTENZA, sustained release dexamethasone 0.4 mg insert following corneal transplant surgery (PKP, DSEK, DMEK) as compared to topical prednisolone acetate 1%.
What is the current status of trial NCT04521140?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2020-10-16. Estimated completion is 2023-01-04.
What conditions does trial NCT04521140 study?
This clinical trial studies the following conditions: Intraocular Pressure, Corneal Edema, Ocular Pain, Corneal Defect, Corneal Transplant.
What interventions are being tested in trial NCT04521140?
The interventions under investigation include: Prednisolone Acetate 1% Oph Susp (DRUG), Dextenza 0.4Mg Ophthalmic Insert (DRUG).
Who is sponsoring clinical trial NCT04521140?
This trial is sponsored by Nicole Fram M.D., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04521140 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
Loteprednol vs. Prednisolone and Fluorometholone
COMPLETED · Phase 4
-
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
COMPLETED · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Effect of Raised End-Tidal pCo2 on Choroidal Volume
RECRUITING · NA
-
IOP Elevation Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.